CK
Colleen Kusy Baird Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
16
Avg Return
Past Year
Past Year
45%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
62.5%
Neutral
37.5%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $12 |
59%
upside
| 2 | +167% |
0
%
| 6 Mar ‘26 4 days ago |
|
|
|
Neutral
Maintained
| $867 |
17%
upside
| 2 | – |
–
| 27 Feb ‘26 11 days ago |
|
|
|
Outperform
Maintained
| $158 |
54%
upside
| 2 | +18% |
0
%
| 18 Nov ‘25 3 months ago |
|
|
|
Neutral
Maintained
| $34 |
10%
downside
| 1 | – |
–
| 11 Nov ‘25 3 months ago |
|
|
|
Outperform
Maintained
| $52 |
165%
upside
| 3 | +3.1% |
0
%
| 31 Oct ‘25 4 months ago |
|
|
|
Outperform
Maintained
| $24 |
140%
upside
| 1 | -9.4% |
0
%
| 3 Oct ‘25 5 months ago |
|
|
|
Outperform
Maintained
| $52 |
73%
upside
| 1 | +36% |
0
%
| 16 Jun ‘25 8 months ago |
|
|
|
Neutral
Maintained
| $6 |
78%
upside
| 3 | – |
–
| 4 Jun ‘25 9 months ago |
|
|
|
Outperform
Maintained
| $41 |
49%
upside
| 1 | +44% |
0
%
| 13 Mar ‘25 1 year ago |
|